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Abstract
Background: The use of  drugs to attenuate the haemodynamic response to laryngoscopy and endotracheal intubation is the stan-
dard of  care during elective surgery. Current evidence is conflicting concerning the best agent and optimal dose for this purpose. 
In the majority of  cases, fentanyl is widely utilized to attenuate haemodynamic responses. Ketamine, an established available drug, 
has been scarcely studied in this regard at low doses and against varying doses of  other common agents.
Objective: To compare the overall occurrence of  hypertension and tachycardia immediately pre-intubation (post-induction) until 
10 minutes post intubation between the study group receiving fentanyl at 1.0 µg/kg and the other receiving ketamine at 0.5 mg/kg, 
to compare the occurrence of  post-induction hypotension and the occurrence of  neuropsychiatric phenomena during emergence 
between the two groups.
Methods: One hundred and eight ASA I and II patients aged 18-65 years scheduled for elective surgery under general anaesthesia 
were randomized into two groups: Control group: received fentanyl 1.0 µg/kg intravenously. Intervention group: received ketamine 
0.5 mg/kg intravenously. General anaesthesia was standardized in both groups. The patients and physicians administering anaesthe-
sia were blinded to the study. Haemodynamic responses were evaluated by determining heart rate and blood pressure immediately 
before laryngoscopy and at 2.5, 5, 7.5 and 10 minutes. Neuropsychiatric phenomena were assessed upon recovery from anaesthesia.
Results: One hundred and eight ASA I and II patients scheduled to undergo elective surgery were included in this study, 54 partic-
ipants (50%) in the fentanyl arm and 54 (50%) in the ketamine arm. Baseline demographic characteristics were similar between the 
groups. There were more hypertensive episodes in the ketamine arm (11%) compared to the fentanyl arm (1.85%), but not achiev-
ing statistical significance: Fisher’s exact test, p=0.06. There was no significant difference in the number of  episodes of  tachycardia 
between the Ketamine group 7/54 (13%) and the fentanyl group, 6/54 (11%); x2=0.05, p=0.82. Hypotensive episodes were more 
common in those who received Fentanyl, 41/54 (76%), compared to ketamine recipients, 21/54 (39%), X2=16.9, p<0.001. The 
use of  Ketamine was associated with less episodes of  hypotension, adjusted odds ratio = 0.18 (95% confidence interval 0.07, 0.45).
Conclusion: We conclude, based upon findings in this study group, that there is no difference in the occurrence of  hypertension 
with the use ketamine at 0.5 mg/kg in combination with Propofol at 2.0 mg/kg. In this regard, ketamine provides a viable alterna-
tive to fentanyl at 1.0 µg/kg for attenuating the pressor response to laryngoscopy and endotracheal intubation. Additionally, our 
results suggest that ketamine may protect against post-induction (pre-laryngoscopy) hypotension.
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Introduction 
General anaesthesia with direct laryngoscopy and en-
dotracheal intubation (LTI) is frequently used in surgi-
cal patients. Even with a trend towards increased use of  
regional and local anaesthetic techniques (with or with-
out sedation), general anaesthesia with LTI remains the 
choice for several forms of  surgery e.g. maxillofacial sur-
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gery, cardiothoracic surgery, laparoscopic abdominal sur-
gery and procedures requiring rapid sequence induction1.
Laryngoscopy and endotracheal intubation is one of  the 
most haemodynamically stimulating points during the 
course of  the general anaesthesia. The mechanisms pro-
posed include a somato-visceral reflex, stimulation of  pro-
prioceptors at the base of  the tongue with catecholamine 
release and vagal inhibition of  the heart2.  This provokes 
a haemodynamic response characterized by an increase in 
heart rate (up to 83%) and blood pressure (up to 80%)3. 
These haemodynamic changes typically start within 5 sec-
onds of  laryngoscopy and peak 1 min after initiation of  
intubation and persist for 5-10 minutes4-6. This may lead 
to myocardial ischemia, ventricular arrhythmia, left ven-
tricular failure and cerebral haemorrhage7.
Various factors affect the magnitude of  this response. A 
variety of  anaesthetic techniques and drugs have been 
studied and are available to control the hemodynam-
ic response to laryngoscopy and intubation7. Induction 
drugs may attenuate adverse hemodynamic responses to 
laryngoscopy and endotracheal intubation7. Well studied 
agents/modalities include opioids, local anaesthetics, beta 
blockers, calcium channel blockers, benzodiazepines, bar-
biturates, alpha adrenergic antagonists, vasodilators, alpha 
2 agonists, angiotensin converting enzyme inhibitors, lor-
noxicam, inhalational anaesthetics, pregabalin and nerve 
blocks3,8-14. In a 2013 Cochrane review of  72 RCTs16, 
all studies reporting arrhythmias were analysed and 49 
trials enrolling lower risk patients revealed a significant 
difference observed between the placebo and treatment 
groups (OR 0.20, 95% CI 0.14 to 0.28, P < 0.00001, I2 
= 44%). This review suggests that even low risk (ASA 
I/II) patients are susceptible to cardiac arrhythmia and 
ECG evidence of  myocardial ischaemia as a consequence 
of  haemodynamic changes related to tracheal intubation. 
Of  these low risk patients, 13% had arrhythmias and 1.4 
% had myocardial ischaemia when a placebo was given 
prior to laryngoscopy and intubation. Pre-induction use 
of  pharmacological agents reduced this risk to 4.5% for 
arrhythmias and nil for myocardial ischaemia16.
These drugs and their various combinations have been 
tried in the past and studies have highlighted their use in 
varying doses for the suppression of  this stress response 
but with significant occurrence of  adverse effects, espe-
cially with use of  higher doses of  opioids9.
Fentanyl is a synthetic opioid analgesic with a potency 
of  approximately 75 -125 times that of  morphine. It is 
the most commonly used agent in Aga Khan University 
Hospital, Nairobi, for attenuating this pressor response. 
Ketamine, a phencyclidine derivative, is an N-Meth-
yl D-Aspartate receptor antagonist that also acts at nu-
merous other sites. It inhibits opioid mu receptors while 
stimulating delta and kappa receptors. Ketamine is in 
wide use as an anaesthetic, sedative and analgesic agent. 
Intravenous induction doses for anaesthesia range from 
1-2mg/kg (with an intramuscular induction dose of  
5-10mg/kg.) Ketamine is widely available yet has scarcely 
been soundly studied as an agent for the attenuation of  
haemodynamic response to LTI20. Indeed, it is known to 
cause hypertension and tachycardia at anaesthetic doses. 
This cardio-stimulatory effect is however minimal to nil 
at sub-anaesthetic/analgesic doses15.
This study was designed to compare the overall occur-
rence of  hypertension in response to laryngoscopy and 
endotracheal intubation between low-dose ketamine ver-
sus fentanyl in patients undergoing general anaesthesia. 
Considering the enormous effect of  anaesthetic drugs on 
the patients’ haemodynamics during and after intubation, 
this study intends to explore a possible alternative regi-
men to reduce this morbidity. Our study question is: does 
low-dose ketamine result in lower occurrence of  post la-
ryngoscopy and intubation tachycardia and hypertension 
compared to fentanyl?
We hypothesized that there is no difference in the occur-
rence of  post-laryngoscopy and intubation hypertension 
and tachycardia in patients who receive pre-laryngoscopy 
and intubation low dose ketamine versus fentanyl. Our 
primary objective was to compare the effect of  low-dose 
ketamine versus fentanyl on the occurrence of  hyper-
tension in patients undergoing general anaesthesia. Our 
secondary objectives were to compare the occurrence of  
tachycardia between the two study groups, compare the 
occurrence of  pre-laryngoscopy and intubation hypoten-
sion between the two study groups and to compare the 
occurrence of  neuropsychiatric phenomena upon recov-
ery from anaesthesia.
Methods
The study was performed following approval from the re-
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search scientific and ethical committees of  the Aga Khan 
University, East Africa. This was a prospective, double 
blinded, and randomized controlled trial. Patients were 
recruited from the outpatient pre-anaesthesia clinics as 
well as the day care and in-patient wards. The target pop-
ulation included patients admitted for elective and urgent 
surgery under general anaesthesia with laryngoscopy and 
endotracheal intubation at the Aga Khan University Hos-
pital, Nairobi.  The sample population included Amer-
ican Society of  Anesthesiologists (ASA) physical status 
(PS) I and II patients going to theatre for elective  surgery 
between November 2015 and April 2016. 
All ASA I and II patients 18-65 years scheduled for elec-
tive surgery aged between 18 and 65 years were included 
in the study. Reasons for exclusion from the study were:
1. History of  allergy or contraindications to any of  the 
study drugs.
2. Patients scheduled for emergency surgery. 
3. Age below 18 years and above 65 years.
4. Hypertension – a known/previously diagnosed hyper-
tensive as per the American Heart Association guidelines.
5. Pregnancy.
6. Dementia/psychiatric illness.
7. Known ischaemic heart disease.
8. Known raised intracranial pressure or intracranial pa-
thology where a rise in intracranial pressure would pose 
a risk or patients scheduled for neurosurgical procedures.
9. History, indicator (Mallampati score) of  or proven dif-
ficult ventilation/laryngoscopy/intubation.
10. Intubation time greater than 30 seconds/Repeat at-
tempts at intubation.
11. Patients who did not agree to the clinical trial. 
Previous studies show incidence of  tachycardia and hy-
pertension of  55% and 40% respectively with fentanyl 
(versus 85% and 80% respectively with controls).3 This 
represents a 30% decrease in tachycardia and hyperten-
sion than control. This study sought to identify a further 
30% decrease in these haemodynamic parameters with 
use of  low dose ketamine (compared to Fentanyl). Using 
this information and assuming 5% significance level and 
power of  80%, a sample size of  80 patients was found 
sufficient to demonstrate a 30% difference in the inci-
dence of  hypertension and of  tachycardia between pa-
tients undergoing general anaesthesia with LTI given low 
dose Ketamine versus Fentanyl. The study was powered 
at 80%. Type 1 error was set at 0.05. Accounting for a 
10% drop-out gave us a total sample size of  88 with 44 
patients in each study arm.
Study participants were recruited after screening to deter-
mine eligibility and obtaining informed consent for the 
study. Participants were screened during the pre-operative 
anaesthesia assessment session in the anaesthesia clinic, 
in-patient wards and day care unit. Consecutive sampling 
was employed such that every available subject eligible for 
selection was recruited. All potential participants received 
a verbal and written explanation on the purpose and pro-
cedure of  the study from the principal investigator and 
written informed consent sought. The patients who gave 
written informed consent were enrolled into the study 
and then randomized. 
The participants were randomly allocated to either arm 
using simple randomization. A random allocation se-
quence was generated by a statistician using a computer 
algorithm and consenting participants were allocated to 
either arm based on the random allocation sequence. The 
principal investigator was not engaged in the generation 
of  the random allocation sequence. The statistician had 
envelopes that were serialized to correspond to the afore-
mentioned random allocation sequence. Once a patient 
gave informed consent, the clinician screening the patient 
attached the envelope to the anaesthesia chart/data col-
lection tool/consent form. Once the participant arrived 
in the pre-operative receiving area of  the main theatres, a 
research assistant not involved in any other aspect of  the 
study received these envelopes containing the allocation 
number that he used to know what drug to give according 
to the allocation chart available to him only. He then pro-
ceeded to prepare the appropriate drug up to a volume 
of  10mL. Identical 10 mL syringes labelled “Study Drug” 
were used. The drug was then presented to the anaesthe-
siologist in the operating theatre. Both Fentanyl and Ket-
amine are colourless/clear liquids and so the presentation 
was identical. In this way, the participant, principal inves-
tigator and the anaesthesiologist in the operating theatre 
remained blinded to the group allocation. Flow diagram 
of  patient distribution is shown in figure 1.
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                      Figure 1. Flow diagram of patient distribution 
 
Screening (Anesthesia clinic, Daycare 
unit, In-patient wards) 
Patient assessed for eligibility by principal investigator 
and appropriately trained research assistant. ELIGIBLE? 
N0 
Yes 
117 
 
Informed consent obtained by principal investigator and 
appropriately trained research assistant? 
Yes 
108 
Patient randomized 
108 
Fentanyl group 
54 
Excluded (continued to 
receive appropriate 
anaesthesia service and 
care) 
No 9 
Ketamine group 
54 
Analysis 108 
On arrival in the operating theatre, standard monitoring 
was applied with automated non-invasive blood pressure 
measurement, electrocardiography and pulse oximetry, 
with the objective of  obtaining the baseline cardiovascu-
lar parameters. Baseline blood pressure was obtained by 
taking three readings and calculating an average of  the 
three readings. 
Intravenous access was obtained and 10mL/kg of  Nor-
mal Saline or Ringer’s Lactate administered over the in-
duction period.
At least 3 minutes of  pre-oxygenation was performed. 
Fentanyl group participants received 1.0  µg/kg fentan-
yl and 2.0 mg/kg propofol as intravenous bolus doses 
5 minutes prior to laryngoscopy. Ketamine group par-
ticipants received 0.5 mg/kg ketamine and 2.0 mg/kg 
propofol as intravenous bolus doses 5 minutes prior to 
laryngoscopy. 0.2 mg/kg Cisatracurium was administered 
as an intravenous bolus dose within 1 minute of  adminis-
tering Fentanyl/Ketamine and Propofol. 
Ventilation with 1% Isoflurane in oxygen via a Mapleson 
A circuit was initiated followed by laryngoscopy with an 
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appropriately sized Macintosh laryngoscope and endotra-
cheal intubation with an appropriately sized cuffed endo-
tracheal tube. This was to commence 3 minutes after the 
administration of  muscle relaxant.
Haemodynamic and other monitoring parameters were 
observed continuously and recorded at 1 minute post in-
duction (on administration of  study drug and Propofol) 
and then at intervals of  2.5 minutes each for the first 10 
minutes.
Upon reversal of  anaesthesia (recovery in the post-anaes-
thesia care unit – PACU) the patient was observed for any 
neuropsychiatric manifestations such as hallucinations 
and confusion not attributed to the usual post-general 
anaesthesia emergence. This information was recorded in 
the data collection tool.
Any episode of  hypertension persisting more than 20 
minutes was to be managed by deepening the plane of  
anaesthesia with Isoflurane or if  refractory, with 10 mg 
boluses of  intravenous labetalol titrated to effect. Any 
incidence of  persistent hypotension was to be managed 
either 3 mg intravenous boluses of  Ephedrine or 50 mcg 
intravenous boluses of  Phenylephrine. Neuropsychiatric 
phenomena were to be identified upon recovery as either 
hallucinations or confusion not attributed to the realm of  
immediate recovery after general anaesthesia. These were 
to be managed with 1 mg intravenous boluses of  Midaz-
olam. Pre-emptive use of  Midazolam (after the end of  
the study) could be administered at the discretion of  the 
anaesthesiologist. Any complications that occurred were 
to be noted by the anaesthesiologist. 
Intraoperative data was collected by the anaesthesiologist 
administering anaesthesia using the data collection form. 
The principal investigator verified all raw data entered 
was complete. Data analysis was undertaken using the 
SPSS version 15. General baseline demographic charac-
teristics (age, sex, ASA status) between the two groups 
were expressed as percentages. Baseline characteristics 
between the two groups were summarised as propor-
tions for categorical variables and as means (±standard 
deviation) or medians (interquartile ranges) for normal-
ly distributed and non-normally distributed continuous 
variables respectively.
Characteristics of  patients who received ketamine and 
fentanyl were compared using chi-squared test or Fisher’s 
exact test for proportions as appropriate. Fisher’s exact 
test was used when any cell value in the two by two ta-
ble was ≤ 5. Student t-test was used to compare means 
for normally distributed continuous variables between 
patients who received Fentanyl and those who received 
Ketamine. Non-parametric test, Wilcoxon rank-sum test, 
was used to compare medians between the two groups 
for non-normally distributed continuous variables. 
The primary outcome was increase of  SBP of  more than 
20% from the baseline (considered clinically significant). 
Proportions in the ketamine and fentanyl arms with pri-
mary outcome were compared using the Fisher’s exact 
test. Similar comparison of  proportions was used for 
secondary outcomes which included the following: the 
occurrence of  tachycardia (heart rate increase more than 
20% from baseline) between the two study groups; oc-
currence of  post-induction, pre-laryngoscopy hypoten-
sion (decrease in MAP of  more than 20%) between the 
two study groups; and incidence of  neuropsychiatric phe-
nomena upon recovery from anesthesia. Chi-square test 
was used for comparison of  proportions where appropri-
ate (when all cell values in the two by two table were > 5). 
The association between the drugs (Ketamine or Fentan-
yl) and hypertension, hypotension and tachycardia was as-
sessed by calculation of  odds ratios (and 95% confidence 
intervals).  Multivariable logistic regression was done, and 
odds ratios calculated, to test for independent association 
between the drugs and the outcome of  interest (hyper-
tension, hypotension and tachycardia). Variables adjusted 
for in the multivariable model were age, ASA status and 
sex. 
Graphical representations showing changes in SBP, MAP, 
DBP and heart rates over times between Ketamine and 
Fentanyl groups were also done. Time to event analyses 
were done and Kaplan Meier survival curves drawn to 
compare time to development of  hypertension or hypo-
tension between the two groups. Logrank test was used 
for statistical comparison of  time 
Results
One hundred and eight ASA I and II patients scheduled 
to undergo elective surgery were included in this study. 
There were 54 participants (50%) in the Fentanyl arm 
and 54 (50%) in the Ketamine arm. Fifty four percent 
(58) were female, 88 (82%) had ASA I status, none had 
neuropsychiatric manifestations, median age was 37 years 
(interquartile range, 29-46), and the mean body weight 
was 68.2(±12.3) kilogram.
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Patients enrolled to Ketamine and Fentanyl groups were 
similar in sex, ASA status, weight and had similar blood 
pressure at baseline as shown in table 1 below. Patients 
randomised to the Ketamine group were generally older 
than those randomised to the Fentanyl arm but this did 
not achieve statistical significance.
Table 1: Comparison of baseline characteristics between fentanyl and ketamine groups 
 
Baseline patients characteristics 
Fentanyl group Ketamine group 
p value n(%) n(%) 
Female Sex 28(52) 30(56) 0.85 
ASA I 44(81) 44(81) 
0.93 ASA II 10(19) 10(18) 
 Mean(±SD) Mean(±SD) p value 
Age (years) 34.4(9.5) 38.2(10.8) 0.053 
Weight (kg)  68.6(11.0) 68.2(12.3) 0.871 
Systolic Blood Pressure (mmHg) 124.4(16.6) 121.0(14.3) 0.255 
Diastolic Blood Pressure (mmHg) 76.5(9.2) 76.5(9.6) 0.967 
Mean Blood Pressure (mmHg) 92.5(11.1) 91.4(10.3) 0.588 
Heart Rate (bpm) 76.6(10.5) 75.9(10.6) 0.74 
 
Seven participants developed hypertension (>20% in-
crease in baseline) after induction during the duration 
of  follow up; 6/54 in the Ketamine arm (11.11%) and 
1/54 was in the Fentanyl arm (1.85%) as shown in table 2. 
Table 2: Proportion of hypertension between fentanyl and ketamine groups 
 Fentanyl 
n(%) 
Ketamine 
n(%) 
Total 
n(%) 
Hypertension post-baseline Absent 52(51) 49(49) 101 
Hypertension post-baseline Present 1(14) 6(86) 7 
Total  Fisher’s exact test, p=0.06 108 
 
There were more hypertensive episodes in the Ketamine 
arm compared to the Fentanyl arm, but not achieving sta-
tistical significance: Fisher’s exact test, p=0.06. 
The cases with hypertension were mainly due to increase 
in mean arterial pressure (n=5) and only 1 case each was 
seen for hypertension due to increase in systolic or dia-
stolic blood pressures. The patient who developed systol-
ic hypertension did so at 7.5 minutes but this was normal 
at 10 minutes and the one who developed diastolic hy-
pertension did so from 1 minute of  follow up but had 
normalised by 10 minutes. At 1 minute, two participants 
had hypertension diagnosed from increase in mean blood 
pressure but these resolved by 7 minutes when 3 others 
had hypertension and two persisted until 10 minutes.
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While accounting for confounders, the association of  use 
of  Ketamine with hypertension after adjusting for sex, 
age and ASA status produced an adjusted odds ratio = 
6.36 (95% confidence interval 0.71, 57.4). This was not 
statistically significant.
Mean blood pressures were higher post-baseline in the 
Ketamine group compared to the Fentanyl group as sum-
marised in table 3. This study was however not powered 
to detect this difference and indeed, this was not deemed 
clinically significant given that the overall occurrence of  
hypertension was not statistically significantly higher with 
the Ketamine than the Fentanyl group.
Table 3: Comparison of blood pressure between fentanyl and ketamine groups 
Time (min) post-
induction 
Fentanyl group Ketamine group 
P  value Mean(±SD 
                               SBP  (mmHg) 
1min  99.4(8.5) 106.7(11.3) <0.001 
2.5min  96.8(8.2) 107.1(11.3) <0.001 
5min  103.0(8.1) 110.7(8.1) <0.001 
7.5min  98.6(8.8) 113.7(10.2) <0.001 
10min 99.0(5.9) 111.9(7.3) <0.001 
                               DBP (mmHg) 
1min  59.6(7.1) 67.5(8.8) <0.001 
2.5min  59.1(7.0) 67.3(8.9) <0.001 
5min 64.2(7.6) 70.0(7.6) <0.001 
7.5min  62.3(8.3) 72.0(7.6) <0.001 
10min 63.5(8.0) 69.6(7.9) <0.001 
                              MAP  (mmHg) 
1min  72.9(6.9) 80.5(9.4) <0.001 
2.5min  71.7(6.8) 80.4(9.6) <0.001 
5min  77.1(7.2) 83.6(7.4) <0.001 
7.5min  74.4(8.0) 85.8(8.3) <0.001 
10min  75.3(6.2) 83.5(6.0) <0.001 
 
 
 
Mean systolic blood pressures were higher in the Ket-
amine arm compared to the Fentanyl arm over the du-
ration of  follow up; Ketamine β-coefficient=7.95(5.96, 
9.95), p<0.001. On assessing the absolute differences in 
mean values, this was not seen as clinically significant. 
The significant outcome measure was the difference from 
baseline rather the difference between the groups. Simi-
larly linear regression done comparing mean MAPs (con-
trolling for sex, age and ASA status) showed higher mean 
MAP in the Ketamine group compared to the Fentanyl 
group during the period of  follow up; Ketamine β-co-
efficient=6.63(5.06, 8.20), p<0.001. Again, on assessing 
the absolute differences in mean values, this was not seen 
as clinically significant. The significant outcome measure 
was the difference from baseline rather the difference be-
tween the groups.
Higher mean diastolic blood pressure were seen in the 
ketamine arm during the period of  follow up, Ketamine 
β-coefficient=6.11(4.67, 7.55), p<0.001. Once again, on 
assessing the absolute differences in mean values, this was 
not seen as clinically significant. The significant outcome 
measure was the difference from baseline rather the dif-
ference between the groups.
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Even though the hypertensive episodes observed in the 
Ketamine group did not reach statistical significance, sur-
vival probability against hypertension was analysed and it 
shows faster development of  hypertension in those treat-
ed with Ketamine, Logrank test, p<0.001. Of  note is that 
in the 10 minute period both the Ketamine and Fentanyl 
groups had a less than 15% probability of  developing hy-
pertension.
A total of  13 (12%) episodes of  tachycardia (>20% in-
crease in baseline heart rate) were seen; 7/54(13%) in the 
Ketamine group and 6/54(11%) in the Fentanyl group, 
showing no significant difference in incidence of  tachy-
cardia, x2=0.05, p=0.82. 
When only considering the means, Ketamine arm had 
higher mean heart rates during follow up compared to 
Fentanyl arm despite similar baseline measurement as 
summarised in table 4. These were however not deemed 
clinically significant; largest difference between the two 
groups = 5.4 bpm. After adjusting for age, sex and ASA 
status, use of  Ketamine was not significantly associated 
with tachycardia during follow up, odds ratio=1.14 (95% 
confidence interval 0.35, 3.67). Linear regression done 
comparing heart rates (controlling for sex, age and ASA 
status) showed higher mean heart rates in Ketamine group 
compared to Fentanyl group during the period of  follow, 
Ketamine β-coefficient=2.26(0.66, 3.86), p=0.006. This 
was not considered clinically significant: mean heart rates 
for both groups ranged between 70 and 80bpm in both 
groups.
Overall, 62(57%) of  participants developed hypotension 
(fall >20% post baseline) during follow up. This was 
more common in those who received Fentanyl, 41/54 
(76%), compared to Ketamine recipients, 21/54 (39%), 
X2=16.9, p<0.001. This suggests a trend towards more 
post-induction hypotension with Fentanyl use (the study 
was not powered to detect this difference). The use of  
Fentanyl was associated with more episodes of  hypoten-
sion, adjusted odds ratio = 5.5 (95% confidence interval 
2.2, 13.9) – adjustment made for age, sex and ASA sta-
tus. Conversely, the use of  Ketamine was associated with 
less episodes of  hypotension, adjusted odds ratio = 0.18 
(95% confidence interval 0.07, 0.45).
Hypotension was seen from 1 minute of  observation 
whether measured by systolic, diastolic, or mean blood 
pressures in both Ketamine and Fentanyl arm and the 
significantly higher episodes in the Fentanyl arms were 
seen from 1 minute and persisted throughout follow up. 
The Survival probability against hypotension was anal-
ysed and it shows faster time to development of  hypo-
tension in the Fentanyl arm during period of  follow up, 
Logrank test, p<0.001, with more than 75% probability 
of  developing hypotension by 10 minutes in the Fentanyl. 
No rescue interventions were employed within the time 
of  the study and no adverse events were recorded.
There was no report of  any patient with hallucinations 
or confusion deemed to be outside of  the realm of  post 
general anaesthesia emergence behaviour.
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Table 4: Comparison of heart rate between fentanyl and ketamine groups 
 
 
Time (min) post-induction 
Fentanyl group Ketamine group 
p value 
Heart Rate (bpm) 
Mean(±SD) 
1min  74.7(10.1) 
75.2(10.7) 0.795 
2.5min 74.9(9.7) 
75.5(9.9) 0.765 
5min 75.2(9.9) 
79.8(10.3) 0.02 
7.5min 71.6(9.8) 
77.0(9.8) 0.005 
10min 70.1(8.9) 
74.7(11.3) 0.021 
 
Discussion
As far as our literature review went, this is the first study 
investigating the use of  the combination of  Ketamine 
and Propofol versus Fentanyl and Propofol, at the cit-
ed doses, to attenuate the haemodynamic response to la-
ryngoscopy and endotracheal intubation. The dosing of  
Propofol and Fentanyl forms part of  the standard of  care 
at our hospital. No rescue interventions were employed 
within the time of  the study and no adverse events were 
recorded. 
We postulated that at an appropriate (and as yet unknown) 
dose, the Ketamine dose would be high enough to con-
fer adequate analgesia needed to reduce the untoward 
haemodynamic responses to laryngoscopy and endotra-
cheal intubation and low enough to not manifest its own 
cardio-stimulant effects while preventing the commonly 
observed drop in blood pressure immediately post-induc-
tion (pre-laryngoscopy). 
In this study, laryngoscopy and endotracheal intubation 
were performed 5 minutes after the administration of  
the induction medication. This was assumed to allow for 
peak effect of  these medications to be attained. 
The key finding of  this study was that the occurrence 
of  hypertension (defined as an increase of  20% from 
baseline values) post laryngoscopy and endotracheal in-
tubation was not significantly higher, p= 0.06 (statistical-
ly or in the author’s opinion, clinically) with the use of  
0.5mg/kg Ketamine than with 1.0 μg/kg Fentanyl use. 
For instance, there was an episode of  increase in SBP 
of  100 vs 121mmHg at 7.5 minutes, of  MAP from 96 to 
118mmHg at 7.5 minutes. On controlling for differences 
in age, sex and ASA status, Ketamine still did not show 
an association with hypertension. Mean blood pressures 
were higher in the Ketamine than the Fentanyl group but 
this was not deemed clinically significant, the greatest 
difference being a range of  88.6 to 105 mmHg versus a 
range of  95.8 to 118.4mmHg in SBP at 2.5 minutes; 66.4 
to 82.4mmHg versus 77.5 to 93.6mmHg in MAP at 7.5 
minutes; 52.1 to 66.1mmHg versus 58.4 to 76.2mmHg in 
DBP at 2.5 minutes for Fentanyl and Ketamine groups 
respectively.
On analysis, there was no statistically significant increase 
in heart rate from baseline with use of  either drug com-
bination, p=0.82. On controlling for differences in age, 
sex and ASA status, Ketamine still did not show an as-
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sociation with tachycardia.  The study was however not 
powered to detect differences in the secondary outcome 
measures. The mean heart rates in the Ketamine group 
were higher than in the Fentanyl group, but, this was not 
deemed clinically significant; the greatest difference in 
range of  mean heart rate was 61.8 to 81.4 bpm versus 
67.2 to 86.8 bpm in the Fentanyl and Ketamine group 
respectively at 7.5 minutes post induction. 
Post induction hypotension also lends to the risk of  myo-
cardial ischaemia and is often seen with opioid based an-
aesthesia induction. There was a statistically significant 
decrease in blood pressure (occurrence of  hypotension) 
post induction (pre-laryngoscopy) in the Fentanyl group 
compared to the Ketamine group, p=<0.001. Again, this 
study was not powered to detect differences in this sec-
ondary outcome measure. On adjusting for confounders, 
Ketamine was still associated with less episodes of  post 
induction hypotension. The post induction hypotension 
observed is likely secondary to peripheral vasodilatory ef-
fect of  Propofol as well as the direct cardio-depressant 
effects of  Fentanyl. 
It is worth noting that the participants’ preoperative fluid 
status was unknown and as such, some of  them may have 
been relatively fluid depleted. This may have unmasked a 
relative intravascular hypovolemia in these patients and 
exaggerated the association of  either drug with this ob-
servation. 
After laryngoscopy and endotracheal intubation, Haya-
kama-Fujii et al demonstrated a significantly greater in-
crease in blood pressure and heart rate above baseline 
values in the Propofol-Ketamine group. Patients received 
Propofol at 2mg/kg plus either Fentanyl 3.0µg/kg, Ket-
amine 0.1mg/kg or Fentanyl 3.0µg/kg and Ketamine 0.1 
mg/kg18. We postulate that the reason for this difference 
from our findings is that the doses are not equianalgesic 
(the Ketamine dose is too low to allow for its analgesia 
to be effective versus the higher dose of  Fentanyl used).
Similar to our study, Singh at al demonstrated statisti-
cally significant increases in mean systolic and diastolic 
blood pressures at all times until 10 minutes post-induc-
tion with a Propofol-Ketamine combination than with 
a Propofol-Fentanyl combination4. That study did not 
however report analysis of  variation of  these haemody-
namic parameters from baseline. This may not have been 
significant, even if  the difference in the means was. Fur-
thermore, it is worth commenting on whether the dif-
ferences observed are of  clinical significance (their study 
demonstrated ≤14 mmHg difference in SBP 122.16 ver-
sus 132.68 and ≤11mmHg difference in DBP 75.20 ver-
sus 86.92 for Fentanyl and Ketamine groups respectively 
within a comparable study period time).
Like our study, the same study demonstrated a statisti-
cally significant increase in pulse rate post induction with 
Propofol-Ketamine than with Propofol-Fentanyl. Again, 
this was a difference in mean heart rates rather than from 
baseline heart rate. The greatest difference in heart rate 
was 14bpm (90 bpm versus 76 bpm in the Ketamine ver-
sus Fentanyl groups respectively at 10minutes post induc-
tion). They also demonstrated a statistically significant fall 
in SBP and DBP with the Fentanyl group in the post-in-
duction pre-laryngoscopy period. 
In their study however, Propofol was used at a dose of  
1.0mg/kg when combined with Ketamine at a dose of  
1.0 mg/kg against Propofol 1.5 mg/kg versus Fentanyl at 
2.0 μg /kg. The anaesthetic dose of  Ketamine is quoted 
as being between 1.0 and 2.0mg/kg and as such it could 
be postulated that the relatively high dose of  ketamine 
allowed for its sympathomimetic effects to manifest. In 
addition, the Propofol dose was on the lower range of  
anaesthetic dosing (usually 1.0 – 2.0 mg/kg) and may also 
have been too low to consistently provide adequate depth 
of  anaesthesia.  
Goyal et al compared the two drugs at similar (but not 
equal) dosages for short surgical procedures19. One group 
was given Ketamine 0.5 mg/kg and the other Fentanyl 
1.5 μg/kg and 2 minutes later given Propofol 2.5 mg/
kg. Laryngeal mask airways were used in this study but 
post-induction, pre-intubation haemodynamic variables 
were noted. There was significant decrease (P<0.05) in 
the systolic and diastolic blood pressure at 1, 3, and 5 
minutes in the Fentanyl group whereas the change was 
insignificant at 10 minutes. This corresponds with the re-
sults of  our study. However, it should be noted that at 
1 minute, Propofol had not been administered and at 3 
minutes the laryngeal mask airway was likely already be-
ing inserted. The difference in methodology renders it 
difficult to compare those results with the results of  this 
study.
African Health Sciences Vol 19 Issue 3, September, 2019 2761
In a study by Honarmand et al, the largest difference be-
tween the Thiopental-Fentanyl and Thiopental-Ketamine 
groups in any blood pressure parameter was 6.7mmHg 
(109.2 versus 115.09 SBP) and a heart rate difference of  
16.2bpm (69.7 versus 85.9), which was statistically signif-
icant (17). In that study, Thiopental was used at 4.0 mg/
kg, Fentanyl at 3.0 μg /kg and Ketamine at 0.1 mg/kg. 
Again, this represented a difference in means and not a 
difference from baseline values. Nevertheless, any differ-
ence in variation from baseline that may exists between 
the two studies may be attributed to the sub-optimal of  
ketamine versus a supra-optimal of  Fentanyl which may 
have consequently produced lower analgesic effects and 
thus less likely to attenuate the pressor response to laryn-
goscopy and endotracheal intubation.
The observations made in our study may, like our as-
sumption while choosing the Ketamine protocol dose, be 
attributed to Ketamine being at a low enough dose that 
its sympathomimetic effects are minimal and still high 
enough to confer effective analgesia deemed necessary to 
attenuate the response to laryngoscopy and endotracheal 
intubation. Propofol was used at a dose of  2.0 mg/kg to 
increase the likelihood of  adequate depth of  anaesthesia.
The findings in this study are in keeping with our null 
hypothesis: there is no difference in the occurrence of  
hypertension post laryngoscopy and endotracheal intuba-
tion with the use of  Ketamine versus Fentanyl.
According to the study protocol, various rescue actions 
and medications were to be employed in the case of  
persistent hypertension or tachycardia. This was not ob-
served in any of  the groups.
There was no report of  any patient with hallucinations or 
confusion deemed outside of  the realm of  post general 
anaesthesia behavior. This data was however not acquired 
by use of  a validated tool. Also, midazolam was some-
times administered within the course of  the anaesthetic 
(but only after the 10 minutes post induction and before 
emergence). As such, it is possible that the 0% occur-
rence of  these neuropsychiatric manifestations may have 
been suppressed by benzodiazepine use. Literature does 
however show that such adverse effects are minimal to 
nil with use of  low dose ketamine and with the combined 
use with Propofol.
Strengths
After a thorough literature review, it appears that follow-
ing years of  research into methods to attenuate the hae-
modynamic response to laryngoscopy and endotracheal 
intubation, this is the first prospective, double blinded 
randomized control trial to employ the study drugs at 
these dose combinations using this methodology. It is 
thus hoped that these findings will add to the fund of  
knowledge concerning maintaining cardiovascular and 
haemodynamic stability in the peri-intubation period of  
the general anaesthetic. 
Limitations
This was not a multi-centre trial. This may affect the gen-
eralizability of  the results obtained from this study. The 
study was powered based on a small number of  single 
centre studies that had similar sample sizes. It was not 
powered to analyse the effect of  the study drugs on 
tachycardia and post-induction hypotension. 
Depth of  anaesthesia may have varied as neither the 
use of  bispectral index (BIS) nor electroencephalogram 
(EEG) was employed. As such, the susceptibility to the 
adverse haemodynamic responses to laryngoscopy and 
endotracheal may have been higher in some patients due 
to inadequate depth of  anaesthesia.
By general Anaesthesiology protocol, patients are required 
to fast for at least 6 hours prior to induction of  anaesthe-
sia. Some participants in this study may have fasted for 
a longer time. Use of  Propofol (known to cause periph-
eral vasodilatation) could unmask a relative intravascular 
hypovolemia. The patients’ preoperative haemodynamic 
status was thus unknown and may have contributed to 
the occurrence of  post induction hypotension.
The logistical and budgetary constraints of  this study 
would not allow for 12 lead electrocardiography monitor-
ing during the study period. The inclusion of  this mon-
itoring would aide in identifying episodes of  myocardi-
al ischaemia, which is what the continued search for an 
“ideal” induction drug or drug combination attempts to 
address. 
Conclusion
Based on the results of  this study, we conclude that there 
is no difference in the occurrence of  hypertension and 
tachycardia with the use of  Ketamine at 0.5 mg/kg in 
combination with Propofol at 2.0 mg/kg. In this regard, 
Ketamine provides a viable alternative to Fentanyl at 1.0 
µg/kg for attenuating the pressor response to laryngosco-
py and endotracheal intubation. Additionally, our results 
suggest that Ketamine may protect against post-induc-
tion hypotension.
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